EP2986319A1 - COMBINATION THERAPY COMPRISING A TOR KINASE INHIBITOR AND N-(3-(5-FLUORO-2-(4-(2-METHOXYETHOXY)PHENYLAMINO)PYRIMIDIN-4-YLAMINO)PHENYL)ACRYLAMIDE FOR TREATING CANCER